ENDOCYTE INC Balance Sheet | Understand Stock

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q3 FY2016 As of Sep 30, 2016	Q2 FY2016 As of Jun 30, 2016	Q1 FY2016 As of Mar 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q3 FY2015 As of Sep 30, 2015	Q2 FY2015 As of Jun 30, 2015	Q1 FY2015 As of Mar 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q3 FY2014 As of Sep 30, 2014	Q2 FY2014 As of Jun 30, 2014	Q1 FY2014 As of Mar 31, 2014	Q4 FY2013 As of Dec 31, 2013
Assets
Current assets:
Cash and cash equivalents
Short-term investments
Receivables
Prepaid expenses
Other assets
Total current assets
Long-term investments
Property and equipment, net
Other noncurrent assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
Accrued wages and benefits
Accrued expenses
Deferred revenue
Current portion of other liabilities
Accrued clinical trial expenses
Accrued expenses and other liabilities
Total current liabilities

Other liabilities, net of current portion
Deferred revenue, net of current portion
Total liabilities
Stockholders’ equity:
Common stock: $0.001 par value, 100,000,000 shares authorized; 48,203,529 and 81,323,300 shares issued and outstanding at December 31, 2017 and September 30, 2018
Additional paid-in capital
Accumulated other comprehensive loss
Retained deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments